« Back to Medicines list

PENTHROX 3mL inhalation vapour, liquid

  • Name:

    PENTHROX 3mL inhalation vapour, liquid

  • Company:
    info
  • Active Ingredients:

    Methoxyflurane

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 24/10/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 24/10/2020
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Click on this link to Download PDF directly

Galen Pharma Ireland Limited

Galen Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Erdotin 300mg Capsules Active Ingredients Erdosteine
Medicine Name Kapake 15mg/500mg Tablets Active Ingredients Codeine Phosphate Hemihydrate, Paracetamol
Medicine Name Kapake 30mg/500mg Tablets Active Ingredients Codeine Phosphate, Paracetamol DC
Medicine Name Laxido Orange, powder for oral solution Active Ingredients Macrogol 3350, Potassium Chloride, Sodium Chloride, Sodium Hydrogen Carbonate
Medicine Name Laxido Paediatric Plain, 6.9 g sachet, powder for oral solution. Active Ingredients Macrogol 3350, Potassium Chloride, Sodium Chloride, Sodium Hydrogen Carbonate
Medicine Name PENTHROX 3mL inhalation vapour, liquid Active Ingredients Methoxyflurane
Medicine Name THORENS 10 000 I.U. /ml oral drops, solution Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name THORENS 25 000 I.U. /2.5 ml oral solution Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name Thorens 25 000 IU capsules, hard Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name Tramake 100mg Tablets Active Ingredients Tramadol Hydrochloride
Medicine Name Tramake 50mg Tablets Active Ingredients Tramadol Hydrochloride
1 - 0 of 11 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15 January 2021 Ed-HCP

Reasons for updating

  • Add New Doc

Updated on 24 October 2020 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 24 October 2020 SPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 6 August 2020 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 28 May 2020 Ed-HCP

Reasons for updating

  • Add New Doc

Updated on 28 May 2020 Ed-HCP

Reasons for updating

  • Add New Doc

Updated on 15 May 2020 Ed-Ptnt

Reasons for updating

  • Add New Doc

Updated on 9 April 2020 SPC

Reasons for updating

  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 14 August 2019 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Updated on 14 August 2019 SPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The name of the Marketing Authorisation Holder (MAH) has changed from Medical Developments Penthrox limited to Medical Developments MD&P Limited.

Updated on 22 March 2019 PIL

Reasons for updating

  • Addition of manufacturer

Updated on 23 January 2019 PIL

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose
  • Change to section 6 - what the product contains

Updated on 23 January 2019 SPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 17 August 2018 SPC

Reasons for updating

  • File format updated to PDF

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 15 August 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 15 August 2017 PIL

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 9 March 2017 SPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 9 March 2017 SPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Update of the instruction diagrams. 

Updated on 7 March 2017 PIL

Reasons for updating

  • Change to section 3 - how to take/use

Updated on 16 August 2016 SPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided

Updated on 15 August 2016 PIL

Reasons for updating

  • New PIL for new product